dc.contributor | Hospital Universitari de Girona Dr Josep Trueta |
dc.contributor.author | Cardellini, Marina |
dc.contributor.author | Hoyles, Lesley |
dc.contributor.author | Latorre Luque, Jèssica |
dc.contributor.author | Davato, Francesca |
dc.contributor.author | Moreno-Navarrete, José Maria |
dc.contributor.author | Ricart, Wifred |
dc.contributor.author | Mayneris-Perxachs, Jordi |
dc.contributor.author | Arnoriaga Rodríguez, María |
dc.contributor.author | Fernández-Real, Jose Manuel |
dc.contributor.author | Puig, Josep |
dc.date.accessioned | 2021-11-23T09:58:47Z |
dc.date.available | 2021-11-23T09:58:47Z |
dc.date.issued | 2021-05-07 |
dc.identifier.citation | Mayneris-Perxachs J, Cardellini M, Hoyles L, Latorre J, Davato F, Moreno-Navarretes JM, et al. Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiome. Microbiome. 2021 May 7;9(1):104. |
dc.identifier.uri | https://hdl.handle.net/11351/6585 |
dc.description | Microbioma gastrointestinal; Ferro; Obesitat |
dc.description.sponsorship | This work was supported by EU-FP7 FLORINASH (Health-F2-2009-241913) to R.B., M.F., J.M.F.R., E.H. and J.K.N. Infrastructure support was provided by the National Institute for Health Research (NIHR) Imperial Biomedical Research Centre (BRC). L.H. was in receipt of an MRC Intermediate Research Fellowship in Data Science (grant number MR/L01632X/1, UK Med-Bio). This work was also partly supported by funding to M.-E.D. (EU METACARDIS under agreement HEALTH-F4-2012-305312, Neuron II under agreement 291840 and the MRC MR/M501797/1) and by grants from the French National Research Agency (ANR-10-LABX-46 [European Genomics Institute for Diabetes]), from the National Center for Precision Diabetic Medicine – PreciDIAB, which is jointly supported by the French National Agency for Research (ANR-18-IBHU- 0001), by the European Union (FEDER), by the Hauts-de-France Regional Council (Agreement 20001891/NP0025517) and by the European Metropolis of Lille (MEL, Agreement 2019_ESR_11) and by Isite ULNE (R-002-20-TALENTDUMAS), also jointly funded by ANR (ANR-16-IDEX-0004-ULNE) the Hauts-de- France Regional Council (Agreement 20002045) and by the European Metropolis of Lille (MEL). J.M.-P. is funded by the Miguel Servet Program from the Instituto de Salud Carlos III (ISCIII CP18/00009), co-funded by the European Social Fund ‘Investing in your future’. María Arnoriaga Rodríguez is funded by a predoctoral Río Hortega contract (CM19/00190, co-funded by European Social Fund ‘Investing in your future’) from the Instituto de Salud Carlos III, Spain. This work was supported by grants to AM from the Spanish Ministry of Science and Innovation (PID2019-105969GB-I00) and Generalitat Valenciana (project Prometeo/2018/133) |
dc.language.iso | eng |
dc.publisher | BMC |
dc.relation.ispartofseries | Microbiome;9(1) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Obesitat |
dc.subject | Ferro |
dc.subject | Fetge |
dc.subject.mesh | Iron, Dietary |
dc.subject.mesh | Obesity |
dc.subject.mesh | Non-alcoholic Fatty Liver Disease |
dc.title | Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiome |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1186/s40168-021-01052-7 |
dc.subject.decs | hierro dietético |
dc.subject.decs | obesidad |
dc.subject.decs | esteatosis hepática no alcohólica |
dc.relation.publishversion | https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-021-01052-7 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Mayneris-Perxachs J, Latorre J, Moreno-Navarrete JM, Arnoriaga-Rodríguez M, Puig J, Ricart W, Fernández-Real JM] Departament de Diabetis, Endocrinologia i Nutrició, Hospital Universitari de Girona Dr. Josep Trueta, Institut Català de la Salut (ICS), Girona, Spain. Departament de Ciències Mèdiques, Universitat de Girona, Girona. Institut d'Investigació Biomèdica de Girona (IDIBGi), Salt, Spain. CIBERobn Pathophysiology of Obesity and Nutrition, Instituto de Salud Carlos III, Girona, Spain. [Cardellini M, Davato F] Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy. [Hoyles L] Section of Biomolecular Medicine, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, Exhibition Road, London, UK. Department of Bioscience, School of Science and Technology, Nottingham Trent University, Nottingham, UK |
dc.identifier.pmid | 33962692 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |